Insider Transactions in Q4 2025 at Health Catalyst, Inc. (HCAT)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 05 2025	Benjamin Landry General Counsel	SELL Open market or private sale	Direct	27,425 -21.52%	$54,850 $2.64 P/Share
Dec 04 2025	Julie Larson Green	SELL Open market or private sale	Direct	47,997 -39.48%	$95,994 $2.67 P/Share
Dec 01 2025	Benjamin Landry General Counsel	SELL Payment of exercise price or tax liability	Direct	14,387 -10.15%	$28,774 $2.9 P/Share

Dec 01 2025	Duncan Gallagher	BUY Grant, award, or other acquisition	Direct	6,209 +4.75%	-
Dec 01 2025	Julie Larson Green	BUY Grant, award, or other acquisition	Direct	5,731 +4.5%	-
Dec 01 2025	Daniel D. Burton Chief Executive Officer	SELL Payment of exercise price or tax liability	Direct	55,715 -3.85%	$111,430 $2.9 P/Share
Dec 01 2025	Jason Alger Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	20,619 -7.72%	$41,238 $2.9 P/Share
Dec 01 2025	Kevin Lee Freeman Chief Commercial Officer	SELL Payment of exercise price or tax liability	Direct	16,401 -4.37%	$32,802 $2.9 P/Share
Dec 01 2025	Linda Llewelyn Chief People Officer	SELL Payment of exercise price or tax liability	Direct	9,762 -6.38%	$19,524 $2.9 P/Share

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

Receive news related to Health Catalyst, Inc.